SPORIDEX DEGROWS AT 10.1%; NEUROBION STILL AHEAD. [2 TABLES] (Ranbaxy Laboratories Ltd's sporidex has reported the highest degrowth of 10.1%).
Publication: Asia Africa Intelligence Wire
Publication Date: 24-JUL-03
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
Ranbaxy Laboratories Ltd's Sporidex has reported the highest degrowth of 10.1%, with sales of Rs623.3 M, among the top ten brands of pharmaceuticals for twelve months ending May 2003.
The Rs183.4 M industry as such has reported a growth of 4.4%. On the other hand,...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
